Effect of Cashew Apple Juice on the Physiological and Psychological Fitness in the Middle Aged and Elderly Volunteers
Study the Effect of Cashew Apple Juice on the Physiological and Psychological Fitness in the Middle Aged and Elderly Volunteers
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
Cashew or Anacardium occidentale L. is a plant in a family of Anacardiaceae. The fruit of cashew or cashew apple may be consumed fresh, but contains high quantities of tannins yielding a bitter taste and dry mouth feel. Therefore, it is more often prepared as beverage. It is rich in carbohydrate and vitamin C. It is also claimed for numerous ailments including antitumor, antimicrobial, urease inhibitory and lipoxygenase activity. In addition, cashew apple juice also has excellent anti-oxidant potential. The preclinical data also demonstrated that cognitive deficit rats induced by cholinotoxin which received A.occidentale or cashew fruit juice for 2 weeks showed the neuroprotective and cognitive enhancing effects.Therefore, the potential benefit of Cashew apple juice on physical fitness and psychological fitness of the middle aged and elderly is focused.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 healthy
Started Dec 2010
Longer than P75 for phase_1 healthy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 11, 2015
CompletedFirst Posted
Study publicly available on registry
September 25, 2015
CompletedMarch 23, 2016
March 1, 2016
3 years
April 11, 2015
March 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognitive processing (P300) and attention (N100) using Event Related Potential
4 months
Secondary Outcomes (11)
Accuracy and speed of working memory using computerized battery test
4 months
Mood evaluation using Bond-laddeer questionnaire
4 months
Psychological symptom using SCL-90 questionnaire
4 months
Malondialdehyde level (MDA) in the serum
4 months
Acetylcholinesterase and monoamine oxidase-B activities in serum
4 months
- +6 more secondary outcomes
Study Arms (3)
placebo
PLACEBO COMPARATORThe placebo and cashew apple fruit juice had the same color and smell
cashew apple juice 120 mg/day
ACTIVE COMPARATORThe subjects who were assigned as the low dose treatment group received cashew apple fruit juice extract at dose of 120 mg/day
cashew apple juice 240 mg/day
ACTIVE COMPARATORThe subjects who were assigned as the high dose treatment group received cashew apple fruit juice extract at dose of 240 mg/day
Interventions
Subject receive the Placebo product (placebo group had same color and smell of treatment groups)
Subject received the cashew apple juice at dose of 120 mg/day after meal
Eligibility Criteria
You may qualify if:
- Live in Khon Kaen, Thailand
- Aged between 55-70 years old
- Body mass index is 18.5 to 24.9
- Signed a written consent form
- In order to ensure the healthy condition , all subjects were subjected to history interviewed by the semi structure form. Moreover they all were assessed physical exam by physician
- All volunteers should not use other nutraceutical compounds or herbs or drugs which influenced on the nervous system function at least 1 month before participating in this study
- On the day of the study, all volunteers felt well and refrain from drinking tea or coffee, or smoking more than 10 pieces/ day
You may not qualify if:
- Cardiovascular disease
- Respiratory disease
- Neuropsychological disorders
- Diabetes
- Liver disease
- Renal disease
- Endocrine dysfunction
- Autoimmune disease
- Hematological disorder
- Cancer
- Brain inflammation, head injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Jintanaporn Wattanathorn
Integrated complementary alternative medicine
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Integrative complementary alternative medicine
Study Record Dates
First Submitted
April 11, 2015
First Posted
September 25, 2015
Study Start
December 1, 2010
Primary Completion
December 1, 2013
Study Completion
December 1, 2014
Last Updated
March 23, 2016
Record last verified: 2016-03